dying from lung cancer
DESCRIPTION
Dying from Lung Cancer. An audit of end of life care MARK SHIPLEY. 1) Standardised approach to end of life care (DNR + LCP). Top ten quality marker. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Dying from Lung Cancer](https://reader035.vdocuments.us/reader035/viewer/2022062717/56812a71550346895d8df412/html5/thumbnails/1.jpg)
An audit of end of life careMARK SHIPLEY
![Page 2: Dying from Lung Cancer](https://reader035.vdocuments.us/reader035/viewer/2022062717/56812a71550346895d8df412/html5/thumbnails/2.jpg)
![Page 3: Dying from Lung Cancer](https://reader035.vdocuments.us/reader035/viewer/2022062717/56812a71550346895d8df412/html5/thumbnails/3.jpg)
DOH End of life care strategy: quality markers and measures for end of life care http://www.dh.gov.uk/dr_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_101684.pdf
![Page 4: Dying from Lung Cancer](https://reader035.vdocuments.us/reader035/viewer/2022062717/56812a71550346895d8df412/html5/thumbnails/4.jpg)
1) 100% of patients who die with lung cancer should have a standardised approach to end of life care, (for example, the Liverpool care pathway) including documentation of resuscitation decisions.
DOH End of life care strategy: quality markers and measures for end of life care http://www.dh.gov.uk/dr_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_101684.pdf
![Page 5: Dying from Lung Cancer](https://reader035.vdocuments.us/reader035/viewer/2022062717/56812a71550346895d8df412/html5/thumbnails/5.jpg)
![Page 6: Dying from Lung Cancer](https://reader035.vdocuments.us/reader035/viewer/2022062717/56812a71550346895d8df412/html5/thumbnails/6.jpg)
Symptoms in last 48hrs lung cancer◦Pain 85% ◦Anxiety 71% ◦Dyspnoea 54% ◦Cough 24% ◦Nausea 21%
![Page 7: Dying from Lung Cancer](https://reader035.vdocuments.us/reader035/viewer/2022062717/56812a71550346895d8df412/html5/thumbnails/7.jpg)
In 100% of patients there should be prescription of symptom controlling drugs via appropriate route at appropriate dose.
2a) Opiate analgesia 2b) Antiemetic 2c) Antisecretory 2d) Benzodiazapine for anxiety
Ellershaw John and Ward Chris, (2003) 'Care of the dying patient: the last hours or days of life.' BMJ, 326: pp30-34.The Liverpool Care Pathway. http://www.liv.ac.uk/mcpcil/liverpool-care-pathway/
![Page 8: Dying from Lung Cancer](https://reader035.vdocuments.us/reader035/viewer/2022062717/56812a71550346895d8df412/html5/thumbnails/8.jpg)
![Page 9: Dying from Lung Cancer](https://reader035.vdocuments.us/reader035/viewer/2022062717/56812a71550346895d8df412/html5/thumbnails/9.jpg)
3) In 100% of patients, if deemed to be in the dying phase then this should be communicated to the patient, and if appropriate, to the relatives (including resuscitation decisions.)
Ellershaw John and Ward Chris, (2003) 'Care of the dying patient: the last hours or days of life.' BMJ, 326: pp30-34.
![Page 10: Dying from Lung Cancer](https://reader035.vdocuments.us/reader035/viewer/2022062717/56812a71550346895d8df412/html5/thumbnails/10.jpg)
October 2008 – September2009 at FRH Cases identified by Clinical Coding 35 Cases with Lung Cancer as cause of
death 1 case excluded as died at QEH
Notes obtained for 33 cases and were reviewed by MDS
Cause of death confirmed on Death Certificates
![Page 11: Dying from Lung Cancer](https://reader035.vdocuments.us/reader035/viewer/2022062717/56812a71550346895d8df412/html5/thumbnails/11.jpg)
![Page 12: Dying from Lung Cancer](https://reader035.vdocuments.us/reader035/viewer/2022062717/56812a71550346895d8df412/html5/thumbnails/12.jpg)
30 Patients DNR◦ 22 Consultant decision◦ 7 SPR decision◦ 1 SHO decision
![Page 13: Dying from Lung Cancer](https://reader035.vdocuments.us/reader035/viewer/2022062717/56812a71550346895d8df412/html5/thumbnails/13.jpg)
9
24
![Page 14: Dying from Lung Cancer](https://reader035.vdocuments.us/reader035/viewer/2022062717/56812a71550346895d8df412/html5/thumbnails/14.jpg)
9/30 Patients with DNR decisions who died of lung cancer had a standardised approach to end of life care
1 patient for resususcitation as died post stenting
1 Patient deteriorated following sudden unexplained deterioration
1Patient no DNR ? Omission
![Page 15: Dying from Lung Cancer](https://reader035.vdocuments.us/reader035/viewer/2022062717/56812a71550346895d8df412/html5/thumbnails/15.jpg)
![Page 16: Dying from Lung Cancer](https://reader035.vdocuments.us/reader035/viewer/2022062717/56812a71550346895d8df412/html5/thumbnails/16.jpg)
![Page 17: Dying from Lung Cancer](https://reader035.vdocuments.us/reader035/viewer/2022062717/56812a71550346895d8df412/html5/thumbnails/17.jpg)
![Page 18: Dying from Lung Cancer](https://reader035.vdocuments.us/reader035/viewer/2022062717/56812a71550346895d8df412/html5/thumbnails/18.jpg)
Opiates given in 18 patients Indication documented in 6 patients In all patients where indication was
documented – opiates were given
![Page 19: Dying from Lung Cancer](https://reader035.vdocuments.us/reader035/viewer/2022062717/56812a71550346895d8df412/html5/thumbnails/19.jpg)
Prescribed in 24 patients - Given in 21 Indication in 6 (4 given)
2b)Benzodiazepines for Anxiety
![Page 20: Dying from Lung Cancer](https://reader035.vdocuments.us/reader035/viewer/2022062717/56812a71550346895d8df412/html5/thumbnails/20.jpg)
Anti-emetics given In 6 patientsIndication in 4 ( Given in 50%)
2c) Antiemetics
![Page 21: Dying from Lung Cancer](https://reader035.vdocuments.us/reader035/viewer/2022062717/56812a71550346895d8df412/html5/thumbnails/21.jpg)
Hyoscine 400mcg s/c prescribed in 12/33 Indication documented in 1 Given in 5 patients
2d) Antisecretion
![Page 22: Dying from Lung Cancer](https://reader035.vdocuments.us/reader035/viewer/2022062717/56812a71550346895d8df412/html5/thumbnails/22.jpg)
Symptoms in last 48hrs lung cancer◦Pain 85% ◦Anxiety 71% ◦Dyspnoea 54% ◦Cough 24% ◦Nausea 21%
![Page 23: Dying from Lung Cancer](https://reader035.vdocuments.us/reader035/viewer/2022062717/56812a71550346895d8df412/html5/thumbnails/23.jpg)
Symptoms in last 48hrs lung cancer◦Pain 85% Appropriate Analgesia 66%
◦Anxiety 71% Appropriate Antianxiety 68
◦Dyspnoea 54% indication documentation?
◦Cough 24% Appropriate Antisecretory 15%
◦Nausea 21% Appropriate Antiemetic 18%
![Page 24: Dying from Lung Cancer](https://reader035.vdocuments.us/reader035/viewer/2022062717/56812a71550346895d8df412/html5/thumbnails/24.jpg)
![Page 25: Dying from Lung Cancer](https://reader035.vdocuments.us/reader035/viewer/2022062717/56812a71550346895d8df412/html5/thumbnails/25.jpg)
End of life discussed with patient in 13/31◦ 1patient admitted unconscious◦ 1patient deteriorated after falling causing LOC
Discussions with family 26/33
![Page 26: Dying from Lung Cancer](https://reader035.vdocuments.us/reader035/viewer/2022062717/56812a71550346895d8df412/html5/thumbnails/26.jpg)
Despite patients with lung cancer being identified as approaching end of life (By DNR) a standardised approach to end of life care is only used in 24%
Anticipatory prescribing is variable, indications are rarely documented and use of drugs is low◦ Increasing indications may increase drug use
End of life is often not discussed with patients◦ Discussions are twice as likely to occur with relatives